News
| Date | Title | |
|---|---|---|
| 29 April 2024 | George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director | READ MORE + |
| 27 September 2023 | Recruitment completes for second Phase III hypertension trial investigating GMRx2 | READ MORE + |
| 12 July 2023 | George Medicines completes recruitment of first Phase III hypertension trial | READ MORE + |
| 15 June 2023 | Spotlight on Professor Otavio Berwanger, The George Institute for Global Health | READ MORE + |
| 21 December 2022 | 2022 – Our Year in Review | READ MORE + |
| 21 December 2022 | Leadership transition at George Medicines | READ MORE + |